01 1Synbias Pharma AG
01 1IDARUBICIN HCL
01 1Switzerland
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-06-15
Pay. Date : 2022-05-31
DMF Number : 36526
Submission : 2021-12-02
Status : Active
Type : II
20
Synbias Pharma Ag, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is IDARUBICIN HCL, with a corresponding US DMF Number 36526.
Remarkably, this DMF maintains an Active status since its submission on December 02, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 15, 2022, and payment made on May 31, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
